10 Followers on Owler
ORPHELIA develops and markets pediatric drugs in oncology, CNS and metabolic diseases... Read more
OverviewCompetitorsNews & Insights
ORPHELIA develops and markets pediatric drugs in oncology, CNS and metabolic diseases... Read more
ORPHELIA Pharma CEO: Hugues Bienayme

CEO

Hugues Bienayme

CEO Approval Rating

67/100

2007

PrivateAcquired by Orphalan SA

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals

Est. Annual Revenue
$5M
Agree?
Est. Employees
<10
Agree?

News

Acquisition
Dec 12, 2025
PR Newswire
ORPHELIA Pharma Was acquired by Orphalan SA for undisclosed amounted

ORPHELIA Pharma Competitors

1Advicenne
2Palladio Biosciences
3Dicerna
4ChemoCentryx
5Immune Design
6Juno Therapeutics
7Inovio
8Axial Therapeutics
9Jounce
10NeuroPace
Unlock 13 + competitors

Trending Companies